120 results
424B3
GRI
GRI Bio Inc
20 May 24
Prospectus supplement
5:50pm
with GAAP. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.
(ff) Tax Status. Except for matters that would … made or filed all United States federal, state and local income and all foreign income and franchise tax returns, reports and declarations required
424B3
GRI
GRI Bio Inc
20 May 24
Prospectus supplement
5:49pm
to any Indebtedness.
(ff) Tax Status. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result … foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes and other
8-K
EX-10.1
GRI
GRI Bio Inc
20 May 24
Entry into a Material Definitive Agreement
4:13pm
with GAAP. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.
(ff) Tax Status. Except for matters that would … ) has made or filed all United States federal, state and local income and all foreign income and franchise tax returns, reports and declarations required
424B5
GRI
GRI Bio Inc
20 May 24
Prospectus supplement for primary offering
4:11pm
federal income tax considerations.
The prospectus supplement and any related free writing prospectus that we may authorize to be provided to you may … incurring any additional indebtedness;
a discussion of any material or special U.S. federal income tax considerations applicable to a series of debt
424B3
GRI
GRI Bio Inc
14 May 24
Prospectus supplement
4:46pm
and subsequent revaluations, valuation allowances relating to deferred tax assets, accrued expenses and estimation of the incremental borrowing rate
424B3
sxzn4xdzr
14 May 24
Prospectus supplement
4:44pm
424B3
rkqzg91x7 qkfqbba1f
28 Mar 24
Prospectus supplement
4:45pm
424B3
csy wcdauevwi
28 Mar 24
Prospectus supplement
4:42pm
424B3
nq5odcj4t vpbhz23suq
2 Feb 24
Prospectus supplement
4:25pm
8-K
EX-4.1
r6de2i23f 4u2p2aere0
2 Feb 24
GRI Bio Announces Pricing of $5.5 Million Public Offering
4:23pm
8-K
EX-10.3
qh50dntbbe2k6u
2 Feb 24
GRI Bio Announces Pricing of $5.5 Million Public Offering
4:23pm
8-K
EX-4.3
t18s7hme
2 Feb 24
GRI Bio Announces Pricing of $5.5 Million Public Offering
4:23pm